Scott received his B.S. in Chemistry from the University of Sheffield in the summer of 2013. As part of his bachelor?s degree he worked for AstraZeneca from Sept 2011 ? Aug 2012 as an organic synthetic chemist. In 2019 he earned his Ph.D. in Chemical Biology from Imperial College London where he worked with Prof. Edward Tate. His thesis focused on developing covalent inhibitors for KLK proteases to decipher their role in prostate cancer progression. Having joined the Bogyo lab in October 2019, Scott now works on developing selective inhibitors and substrates for serine hydrolases in cancer and pathogenic bacteria by using diverse chemical libraries and phage-display approaches.
Matthew Bogyo, Postdoctoral Faculty Sponsor